HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+13.7%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.37B
AUM Growth
+$2.37B
(-13%)
Cap. Flow
-$536M
Cap. Flow
% of AUM
-22.65%
Top 10 Holdings %
Top 10 Hldgs %
50.33%
Holding
61
New
23
Increased
10
Reduced
11
Closed
14
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$105M |
| 2 |
AGN
Allergan plc
AGN
|
$90.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
$65.9M |
| 4 |
Icon
ICLR
|
$55.8M |
| 5 |
UnitedHealth
UNH
|
$54.2M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$165M |
| 2 |
CVS Health
CVS
|
$153M |
| 3 |
Intuitive Surgical
ISRG
|
$144M |
| 4 |
LivaNova
LIVN
|
$139M |
| 5 |
CELG
Celgene Corp
CELG
|
$125M |
Sector Composition
| 1 | Healthcare | 91.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Danaher
DHR
$147B
| $139M | 5.6% | 1,050,720 -453,030 | -30% | -$59.8M |
|
|
2
UnitedHealth
UNH
$281B
| $138M | 5.56% | 556,560 +219,280 | +65% | +$54.2M |
|
|
3
Zimmer Biomet
ZBH
$21B
| $136M | 5.49% | 1,063,190 +818,994 | +335% | +$105M |
|
4
Medtronic
MDT
$119B
| $134M | 5.41% | 1,469,190 -3,600 | -0.2% | -$328K |
|
|
5
Neurocrine Biosciences
NBIX
$13.8B
| $134M | 5.4% | 1,516,090 +747,460 | +97% | +$65.9M |
|
6
Haemonetics
HAE
$2.63B
| $119M | 4.8% | 1,357,410 +257,270 | +23% | +$22.5M |
|
7
Madrigal Pharmaceuticals
MDGL
$9.76B
| $112M | 4.51% | 891,990 +203,100 | +29% | +$25.4M |
|
8
Merck
MRK
$210B
| $105M | 4.22% | 1,256,810 +632,730 | +101% | +$52.6M |
|
|
AGN
9
DELISTED
Allergan plc
AGN
| $90.4M | 3.65% | +617,760 | New | +$90.4M |
|
10
DexCom
DXCM
$29.5B
| $87M | 3.51% | 730,100 -738,652 | -50% | -$88M |
|
|
XENT
11
DELISTED
Intersect ENT, Inc
XENT
| $82.7M | 3.34% | 2,571,910 +81,800 | +3% | +$2.63M |
|
|
12
Intuitive Surgical
ISRG
$170B
| $76.9M | 3.1% | 134,690 -253,230 | -65% | -$144M |
|
|
RDUS
13
DELISTED
Radius Health, Inc.
RDUS
| $73.4M | 2.97% | 3,680,949 -43,000 | -1% | -$857K |
|
14
Humana
HUM
$36.5B
| $68.7M | 2.77% | 258,140 +193,310 | +298% | +$51.4M |
|
15
Vertex Pharmaceuticals
VRTX
$100B
| $62.3M | 2.52% | 338,770 +145,960 | +76% | +$26.8M |
|
16
IQVIA
IQV
$32.4B
| $57.9M | 2.34% | 402,840 -367,710 | -48% | -$52.9M |
|
|
17
Icon
ICLR
$13.8B
| $55.8M | 2.26% | +408,730 | New | +$55.8M |
|
18
Centene
CNC
$14.3B
| $54M | 2.18% | +1,016,400 | New | +$54M |
|
|
HZNP
19
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $52.6M | 2.13% | +1,991,329 | New | +$52.6M |
|
20
Boston Scientific
BSX
$156B
| $49.8M | 2.01% | 1,296,960 -497,650 | -28% | -$19.1M |
|
|
BLUE
21
DELISTED
bluebird bio
BLUE
| $47.7M | 1.93% | +302,890 | New | +$47.7M |
|
22
Thermo Fisher Scientific
TMO
$186B
| $43.1M | 1.74% | +157,520 | New | +$43.1M |
|
23
Becton Dickinson
BDX
$55.3B
| $41.3M | 1.67% | +165,320 | New | +$41.3M |
|
24
Gilead Sciences
GILD
$140B
| $40.5M | 1.64% | +623,490 | New | +$40.5M |
|
|
MYOK
25
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $38M | 1.53% | +730,760 | New | +$38M |
|